{"id":"https://openalex.org/W1969754111","doi":"https://doi.org/10.9758/cpn.2012.10.2.94","title":"Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration","display_name":"Effects of the Antioxidant Sulforaphane on Hyperlocomotion and Prepulse Inhibition Deficits in Mice after Phencyclidine Administration","alternate_titles":[],"publication_year":2012,"publication_date":"2012-08-28","ids":{"openalex":"https://openalex.org/W1969754111","doi":"https://doi.org/10.9758/cpn.2012.10.2.94","mag":"1969754111","pmid":"https://pubmed.ncbi.nlm.nih.gov/23430731","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3569145"},"language":"en","primary_location":{"id":"doi:10.9758/cpn.2012.10.2.94","doi":"https://doi.org/10.9758/cpn.2012.10.2.94","is_oa":true,"landing_page_url":"https://doi.org/10.9758/cpn.2012.10.2.94","pdf_url":"https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2012.10.2.94","source":{"id":"https://openalex.org/S2764824292","display_name":"Clinical Psychopharmacology and Neuroscience","issn_l":"1738-1088","issn":["1738-1088","2093-4327"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","kci-registered","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4404678347","host_organization_name":"Korean College of Neuropsychopharmacology","host_organization_lineage":["https://openalex.org/P4404678347"],"host_organization_lineage_names":["Korean College of Neuropsychopharmacology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Psychopharmacology and Neuroscience","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W1969754111"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2012.10.2.94","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5081678604","display_name":"Yumi Shirai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yumi Shirai","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066404161","display_name":"Y\u016bk\u014d Fujita","orcid":"https://orcid.org/0000-0002-0781-3237","observed_orcids":["https://orcid.org/0000-0002-0781-3237"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yuko Fujita","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032453300","display_name":"Kenji Hashimoto","orcid":"https://orcid.org/0000-0002-8892-0439","observed_orcids":["https://orcid.org/0000-0002-8892-0439"]},"institutions":[{"id":"https://openalex.org/I159385669","display_name":"Chiba University","ror":"https://ror.org/01hjzeq58","country_code":"JP","type":"education","lineage":["https://openalex.org/I159385669"]},{"id":"https://openalex.org/I4210162351","display_name":"Center for Forensic Mental Health, Chiba University","ror":"https://ror.org/05b0gpy83","country_code":"JP","type":"healthcare","lineage":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"Kenji Hashimoto","raw_affiliation_strings":["Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Clinical Neuroscience, Chiba University Center for Forensic Mental Health, Chiba, Japan","institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032453300"],"corresponding_institution_ids":["https://openalex.org/I159385669","https://openalex.org/I4210162351"],"apc_list":null,"apc_paid":null,"fwci":2.142,"has_fulltext":true,"cited_by_count":58,"citation_normalized_percentile":{"value":0.84879632,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":99},"biblio":{"volume":"10","issue":"2","first_page":"94","last_page":"98"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sulforaphane","display_name":"sulforaphane","score":1.0},{"id":"https://openalex.org/keywords/phencyclidine","display_name":"phencyclidine","score":0.9229999780654907},{"id":"https://openalex.org/keywords/prepulse-inhibition","display_name":"prepulse inhibition","score":0.8040000200271606},{"id":"https://openalex.org/keywords/hyperlocomotion","display_name":"hyperlocomotion","score":0.996999979019165},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.8259999752044678},{"id":"https://openalex.org/keywords/schizophrenia","display_name":"schizophrenia","score":0.6340000033378601},{"id":"https://openalex.org/keywords/nmda-receptor-antagonist","display_name":"NMDA receptor antagonists","score":0.921999990940094},{"id":"https://openalex.org/keywords/antioxidants","display_name":"antioxidants","score":0.6060000061988831},{"id":"https://openalex.org/keywords/antipsychotic-activity","display_name":"antipsychotic activity","score":0.968999981880188},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.6179999709129333}],"concepts":[{"id":"https://openalex.org/C141421786","wikidata":"https://www.wikidata.org/wiki/Q1128897","display_name":"Prepulse inhibition","level":3,"score":0.9102277755737305},{"id":"https://openalex.org/C2778851735","wikidata":"https://www.wikidata.org/wiki/Q407324","display_name":"Phencyclidine","level":4,"score":0.8888721466064453},{"id":"https://openalex.org/C2780841255","wikidata":"https://www.wikidata.org/wiki/Q424489","display_name":"Sulforaphane","level":2,"score":0.7762171626091003},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7313221096992493},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.602825403213501},{"id":"https://openalex.org/C67018056","wikidata":"https://www.wikidata.org/wiki/Q414896","display_name":"NMDA receptor","level":3,"score":0.5328398942947388},{"id":"https://openalex.org/C2778004101","wikidata":"https://www.wikidata.org/wiki/Q133948","display_name":"Antioxidant","level":2,"score":0.45690762996673584},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.44187620282173157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.41505929827690125},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.41484537720680237},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.40205779671669006},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.25411540269851685},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.206513911485672},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.06097427010536194},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.052149683237075806}],"mesh":[],"locations_count":5,"locations":[{"id":"doi:10.9758/cpn.2012.10.2.94","doi":"https://doi.org/10.9758/cpn.2012.10.2.94","is_oa":true,"landing_page_url":"https://doi.org/10.9758/cpn.2012.10.2.94","pdf_url":"https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2012.10.2.94","source":{"id":"https://openalex.org/S2764824292","display_name":"Clinical Psychopharmacology and Neuroscience","issn_l":"1738-1088","issn":["1738-1088","2093-4327"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","kci-registered","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4404678347","host_organization_name":"Korean College of Neuropsychopharmacology","host_organization_lineage":["https://openalex.org/P4404678347"],"host_organization_lineage_names":["Korean College of Neuropsychopharmacology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Psychopharmacology and Neuroscience","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2575951","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/3569145","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmid:23430731","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23430731","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3569145","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3569145/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clin Psychopharmacol Neurosci","raw_type":"Text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.796.8738","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.796.8738","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"ftp://ftp.ncbi.nlm.nih.gov/pub/pmc/c8/96/cpn-10-94.PMC3569145.pdf","raw_type":"text"}],"best_oa_location":{"id":"doi:10.9758/cpn.2012.10.2.94","doi":"https://doi.org/10.9758/cpn.2012.10.2.94","is_oa":true,"landing_page_url":"https://doi.org/10.9758/cpn.2012.10.2.94","pdf_url":"https://www.cpn.or.kr/journal/download_pdf.php?doi=10.9758/cpn.2012.10.2.94","source":{"id":"https://openalex.org/S2764824292","display_name":"Clinical Psychopharmacology and Neuroscience","issn_l":"1738-1088","issn":["1738-1088","2093-4327"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","kci-registered","norway-1","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4404678347","host_organization_name":"Korean College of Neuropsychopharmacology","host_organization_lineage":["https://openalex.org/P4404678347"],"host_organization_lineage_names":["Korean College of Neuropsychopharmacology"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Psychopharmacology and Neuroscience","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320325772","display_name":"National Center of Neurology and Psychiatry","ror":"https://ror.org/0254bmq54"},{"id":"https://openalex.org/F4320334764","display_name":"Japan Society for the Promotion of Science","ror":"https://ror.org/00hhkn466"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1969754111.pdf","grobid_xml":"https://content.openalex.org/works/W1969754111.grobid-xml"},"referenced_works_count":56,"referenced_works":["https://openalex.org/W1907720276","https://openalex.org/W1963479676","https://openalex.org/W1965707086","https://openalex.org/W1971573216","https://openalex.org/W1972283659","https://openalex.org/W1974046746","https://openalex.org/W1980967004","https://openalex.org/W1983104541","https://openalex.org/W1984254481","https://openalex.org/W1985093720","https://openalex.org/W1989397869","https://openalex.org/W1994883992","https://openalex.org/W1996179584","https://openalex.org/W2003614392","https://openalex.org/W2004310280","https://openalex.org/W2005756201","https://openalex.org/W2017966444","https://openalex.org/W2019320775","https://openalex.org/W2021374816","https://openalex.org/W2025801301","https://openalex.org/W2028884770","https://openalex.org/W2030584066","https://openalex.org/W2031702230","https://openalex.org/W2033616412","https://openalex.org/W2034973586","https://openalex.org/W2034984455","https://openalex.org/W2042676846","https://openalex.org/W2053006968","https://openalex.org/W2054002536","https://openalex.org/W2062355133","https://openalex.org/W2063765492","https://openalex.org/W2067335226","https://openalex.org/W2069656785","https://openalex.org/W2070290296","https://openalex.org/W2071199266","https://openalex.org/W2081128169","https://openalex.org/W2084873146","https://openalex.org/W2086593869","https://openalex.org/W2090223035","https://openalex.org/W2093248761","https://openalex.org/W2103688079","https://openalex.org/W2103989133","https://openalex.org/W2123950263","https://openalex.org/W2126316244","https://openalex.org/W2129866650","https://openalex.org/W2130335246","https://openalex.org/W2140156016","https://openalex.org/W2153784874","https://openalex.org/W2158137297","https://openalex.org/W2161790296","https://openalex.org/W2162836113","https://openalex.org/W2171779677","https://openalex.org/W2323389168","https://openalex.org/W2331405150","https://openalex.org/W2801179356","https://openalex.org/W4246484625"],"related_works":["https://openalex.org/W2081128169","https://openalex.org/W2804413708","https://openalex.org/W2129296188","https://openalex.org/W4214651436","https://openalex.org/W2102779363","https://openalex.org/W4224944006","https://openalex.org/W2511315166","https://openalex.org/W3174082179","https://openalex.org/W1882423297"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Accumulating":[1],"evidence":[2],"suggests":[3],"that":[4,16,159,174],"oxidative":[5],"stress":[6],"plays":[7],"a":[8,58,152,178],"role":[9],"in":[10,42,55,84,120,143,151,164],"the":[11,17,33,36,62,85,140],"pathophysiology":[12],"of":[13,35,61,70,92,102,131,168],"schizophrenia":[14],"and":[15,50,74,81,113,135],"potent":[18,37],"antioxidants":[19],"may":[20,176],"be":[21,177],"potential":[22,179],"therapeutic":[23,180],"drugs":[24],"for":[25,182],"schizophrenia.":[26,169,183],"This":[27],"study":[28],"was":[29],"undertaken":[30],"to":[31],"examine":[32],"effects":[34],"antioxidant":[38],"sulforaphane":[39],"(SFN),":[40],"found":[41],"cruciferous":[43],"vegetables,":[44],"on":[45,79],"behavioral":[46],"abnormalities":[47],"(e.g.,":[48],"hyperlocomotion":[49,80,119],"prepulse":[51],"inhibition":[52],"[PPI]":[53],"deficits)":[54],"mice":[56,89,121,144],"after":[57,90,122,145],"single":[59],"administration":[60,91,124,130,147],"N-methyl-D-aspartate":[63],"(NMDA)-receptor":[64],"antagonist":[65],"phencyclidine":[66],"(PCP).":[67],"METHODS:":[68],"Effects":[69],"SFN":[71,103,132,160,175],"(3,":[72,133],"10,":[73,134],"30":[75,136],"mg/kg,":[76,95,105,115,126,137,149],"intraperitoneally":[77,106],"[i.p.])":[78],"PPI":[82,141],"deficits":[83,142],"adult":[86],"male":[87],"ddY":[88],"PCP":[93,123,146],"(3.0":[94,125,148],"subcutaneously":[96,127],"[s.c.])":[97],"were":[98],"examined.":[99],"RESULTS:":[100],"Administration":[101],"(30":[104],"[i.p.]),":[107],"but":[108],"not":[109],"low":[110],"doses":[111],"(3":[112],"10":[114],"i.p.),":[116],"significantly":[117],"attenuated":[118,139],"[s.c.]).":[128],"Furthermore,":[129],"i.p.)":[138],"s.c.)":[150],"dose-dependent":[153],"manner.":[154],"CONCLUSION:":[155],"These":[156],"results":[157],"suggest":[158],"has":[161],"antipsychotic":[162],"activity":[163],"an":[165],"animal":[166],"model":[167],"Therefore,":[170],"it":[171],"is":[172],"likely":[173],"drug":[181]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W1969754111","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":8},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":2}],"updated_date":"2026-11-19T14:11:59.513116","created_date":"2016-06-24T00:00:00"}
